期刊文献+

糖尿病肾病患者抵抗素与胰岛素抵抗的关系及临床意义 被引量:8

Clinical significance and the correlations between serum resistin and insulin resistance in type 2 diabetes patients with nephropathy
下载PDF
导出
摘要 目的探讨糖尿病肾病(DN)患者血清抵抗素与胰岛素抵抗(IR)的关系及临床意义。方法检测61例2型糖尿病(T2DM)患者(DN组31例、无DN组30例)及30例健康对照者的血清抵抗素、空腹血糖(FPG)、空腹胰岛素(FIns)及胰岛素抵抗指数(Hom a-IR),分析血清抵抗素水平与各检测指标的相关性。结果与对照组比较,DN组、无DN组的血清抵抗素、FPG、FIns、Hom a-IR均明显升高(P均<0.05);与无DN组比较,DN组上述指标虽有升高趋势,但均无统计学差异(P均>0.05)。相关分析显示,DN组血清抵抗素水平与FPG、FIns、Hom a-IR均呈显著正相关(P<0.05)。结论抵抗素与DN患者的IR密切相关,检测T2DM患者的血清抵抗素变化,在一定程度上可反映其肾脏病变。 Objective To explore the correlations between serum resistin and insulin resistance in type 2 diabetes patients with nephropathy and analyze its clinical significance. Methods To examine the serum resistin, blood glucose and the index of insulin resistance separately in 31 type 2 diabetic patients with nephropathy, 30 type 2 diabetic patients without nephropathy and 30 normal control subjects, and to analyze correlation between serum resistin and every index level. Resuits The serum levels of resistin, FPG, Fins and Homa-IR in type 2 diabetic patients with or without nephropathy were significantly increased as compared with normal controls ( P 〈 0.05 ). Though there was no significant difference in all the above dates in type 2 diabetic patients with or without nephropathy( P 〉 0.05 ), the absolute values in the former were higher than those in the latter. Correlation analysis showed the serum resistin levels in type 2 diabetic patients with nephropathy were positively correlated with the levels of FPG, Fins and Homa-IR( P 〈 0.05 ). Conehtsions Resistin is intimately cor- related with the insulin resistance of type 2 diabetic patients with nephropathy. The serum level of resistin can in a certain reflect the destroy degree of diabetic nephropathy.
出处 《山东医药》 CAS 北大核心 2009年第37期3-4,共2页 Shandong Medical Journal
基金 河北省科学技术研究与发展计划项目(09276101D-6)
关键词 糖尿病 2型 糖尿病肾病 抵抗素 胰岛素抵抗 diabetes mellitus, type 2 diabetic nephropathies resistin insulin resistance
  • 相关文献

参考文献8

  • 1Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes [ J ]. Nature, 2001,409 ( 6818 ) : 307-312.
  • 2Kusminski CM, McTernan PG, Kumar S. Role of resistin in obesity, insulin resistance and type 2 diabetes [ J ]. Clin Sci ( Lond ) , 2005,109 ( 3 ) :243-256.
  • 3Szoke E, Gerich JE. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus[ J]. Compr Ther, 2005, 31(2) :106-112.
  • 4Mojiminiyi OA, Abdella NA. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus [J]. Scand J Clin Lab Invest, 2007,67(2) :215-225.
  • 5Fain JN. Release of interleukins and other inflammatory eytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells[J]. Vitam Horm, 2006,74(5) :443-477.
  • 6Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance [ J]. Eur Cytokine Netw, 2006,17 ( 1 ) :4-12.
  • 7章建梁,秦永文,郑兴,邱健力,毛红娟,曹爱芳,贾伟平,郭冀珍.高血压患者血清抵抗素、瘦素与血糖水平相关性的比较[J].中国临床康复,2003,7(18):2526-2527. 被引量:23
  • 8Osawa H, Oehi M, Kato K, et al. Serum resistin is associated with the severity of microangiopathies in type 2 diabetes [ J ]. Biochem Biophys Res Commun, 2007, 355 (2) :342-346.

二级参考文献1

共引文献22

同被引文献141

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部